Published in J Neuroendocrinol on December 01, 1999
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Family-B G-protein-coupled receptors. Genome Biol (2001) 1.75
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol (2012) 1.64
Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular Med (2005) 0.99
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci U S A (2003) 0.97
The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion. J Biol Chem (2007) 0.95
Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells. Mol Immunol (2010) 0.89
Pituitary adenylate cyclase-activating polypeptide stimulates glucose production via the hepatic sympathetic innervation in rats. Diabetes (2010) 0.84
Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis. ASN Neuro (2011) 0.84
Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors. Am J Pathol (2009) 0.83
STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons. J Mol Neurosci (2012) 0.83
PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells. Br J Pharmacol (2014) 0.82
Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity. Front Endocrinol (Lausanne) (2013) 0.82
PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells. Peptides (2011) 0.82
Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors. J Neurochem (2007) 0.81
Consequences of splice variation on Secretin family G protein-coupled receptor function. Br J Pharmacol (2012) 0.81
Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line. Br J Pharmacol (2009) 0.79
Should pharmacologists care about alternative splicing? IUPHAR Review 4. Br J Pharmacol (2014) 0.79
PACAP38 and PACAP6-38 exert cytotoxic activity against human retinoblastoma Y79 cells. J Mol Neurosci (2014) 0.77
Characterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity. J Neuroendocrinol (2007) 0.77
Homology modeling and molecular docking of human pituitary adenylate cyclase‑activating polypeptide I receptor. Mol Med Rep (2014) 0.75
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci (1999) 1.87
Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol Genomics (2000) 1.71
Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab (2000) 1.71
Longitudinal analysis of multiple indicators of health decline among spousal caregivers. Ann Behav Med (1997) 1.68
Effects of cholera and E. coli enterotoxins on cyclic adenosine 3',5'-monophosphate levels and intermediary metabolism in the thyroid. Endocrinology (1973) 1.59
Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab (1997) 1.56
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors. J Pathol (1997) 1.52
Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry (2000) 1.49
Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry (1996) 1.45
Efficacy and tolerability of formoterol Turbuhaler in children. Int J Clin Pract (2003) 1.43
Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Arch Dis Child (1986) 1.40
Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy (2003) 1.39
Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med (1997) 1.34
Circadian phase in adults of contrasting ages. Chronobiol Int (2005) 1.21
Giant calculus of the posterior urethra following recurrent penile urethral stricture. Urol Int (2002) 1.16
Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry (1998) 1.15
Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry (2000) 1.12
Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry (1997) 1.08
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging (1996) 1.07
Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology (Berl) (1992) 1.04
Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res (1993) 1.02
Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy. BJU Int (2002) 0.99
Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child (1987) 0.97
Control of aldosterone secretion during sodium restriction: adrenal receptor regulation and increased adrenal sensitivity to angiotensin II. Proc Natl Acad Sci U S A (1978) 0.97
A new concept for control of the estrous cycle of the ewe based on the temporal relationships between luteinizing hormone, estradiol and progesterone in peripheral serum and evidence that progesterone inhibits tonic LH secretion. Endocrinology (1977) 0.97
Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol Psychiatry (2003) 0.96
Molecular biology of the CRH receptors-- in the mood. Peptides (2001) 0.95
Plasma cortisol and neuropeptide Y in female victims of intimate partner violence. Psychoneuroendocrinology (2003) 0.95
How to treat blunt kidney ruptures: primary open surgery or conservative treatment with deferred surgery when necessary? Eur Urol (2001) 0.94
Angiotensin II regulates its receptor sites in the adrenal glomerulosa zone. Nature (1978) 0.92
The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. J Neurochem (1999) 0.91
Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues. Ann N Y Acad Sci (1987) 0.91
Specific [3H] beta-phenylethylamine binding sites in rat brain. Eur J Pharmacol (1982) 0.91
Generalized subcutaneous emphysema caused by injection of air into the penis for autoerotic purposes. Case Rep Nephrol Urol (2013) 0.91
GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation. Am J Physiol Regul Integr Comp Physiol (2001) 0.90
Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav (1993) 0.90
Molecular Properties of the CRF Receptor. Trends Endocrinol Metab (2008) 0.89
A computer system for on-line decoding of ultrasonic Doppler signals from blood flow measurement. Ultrasonics (1977) 0.88
Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution. Eur J Biochem (1998) 0.88
Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther (1990) 0.87
Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides (1985) 0.87
Individual behavioral and neuroendocrine differences in responsiveness to audiogenic stress. Pharmacol Biochem Behav (1989) 0.86
CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol (1988) 0.86
Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor. Peptides (1993) 0.86
Distribution of corticotropin-releasing factor receptors in primate brain. Proc Natl Acad Sci U S A (1986) 0.85
Comparison of two budesonide dry powder inhalers in the treatment of asthma in children. J Aerosol Med (2004) 0.85
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proc Natl Acad Sci U S A (1998) 0.85
Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Neuropsychopharmacology (1998) 0.84
Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology (1987) 0.83
Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy. J Allergy Clin Immunol (1999) 0.83
Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J Neuroendocrinol (1999) 0.83
Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biol Psychiatry (1997) 0.83
Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides (2001) 0.82
Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatr (1996) 0.82
Aging effects on the startle response and startle plasticity in Fischer F344 rats. Neurobiol Aging (1998) 0.81
Stress: an overview of the literature with emphasis on job-related strain and intervention. Adv Ther (1995) 0.81
Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology (1992) 0.81
Hormonal responses to d- and d,l-fenfluramine in healthy human subjects. Neuropsychopharmacology (1996) 0.80
A sex-related pattern of gonadotropin secretion in the castrated rat: effects of changing the inhibitory steroid or pituitary LH content. Biol Reprod (1977) 0.80
Neuropeptide Y radio-immunoassay: characterization and application. Clin Exp Pharmacol Physiol (1991) 0.80
Characteristics of [3H](+)-amphetamine binding sites in the rat central nervous system. Life Sci (1984) 0.80
G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology (2001) 0.80
Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system. Neuroendocrinology (1986) 0.80
Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med (1998) 0.80
Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. Int Clin Psychopharmacol (1995) 0.79
A multivariate twin study of hippocampal volume, self-esteem and well-being in middle-aged men. Genes Brain Behav (2012) 0.79
Negative feedback action of progesterone on tonic luteinizing hormone secretion in the ewe: dependence on the ovaries. Endocrinology (1977) 0.79
Prolactin response to D-fenfluramine in outpatients with major depression. Psychiatry Res (1998) 0.79
Pituitary regulation of Leydig cell function in the adult male rat. J Endocrinol (1977) 0.79
The daytime alarm: a useful device for the treatment of children with daytime incontinence. J Urol (2006) 0.78
Characterization of angiotensin II receptors in the anterior pituitary gland. Mol Cell Endocrinol (1982) 0.78
The neurosteroid allopregnanolone modulates oxytocin expression in the hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol (2000) 0.78
[Impact of preoperative pain on postoperative pain chronification. Six-month follow-up after urologic surgery]. Urologe A (2011) 0.77
Central corticotropin releasing factor reduces natural cytotoxicity. Time course of action. Neuropsychopharmacology (1989) 0.77
Changes in brain corticotropin-releasing factor messenger RNA expression in aged Fischer 344 rats. Brain Res (1999) 0.77
Interaction of gdt1 and protein kinase A (PKA) in the growth-differentiation-transition in Dictyostelium. Differentiation (2001) 0.77
Sympathetic alterations after sodium restriction and short-term captopril administration. J Am Coll Cardiol (1993) 0.77
Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors. Biol Psychiatry (1999) 0.76
Testicular receptors for luteinizing hormone after immunoneutralization of gonadotrophin releasing hormone in the male rat. J Endocrinol (1977) 0.76
Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers. Psychoneuroendocrinology (1997) 0.76
The role of PKC signaling in CRF-induced modulation of startle. Psychopharmacology (Berl) (2013) 0.76
Glucostatic regulation of (+)-[3H]amphetamine binding in the hypothalamus: correlation with Na+,K+-ATPase activity. Proc Natl Acad Sci U S A (1985) 0.76
Cortisol and growth hormone responses to the 5-HT1A agonist gepirone in depressed patients. Biol Psychiatry (1990) 0.76
Adaptation to chronic stress. Temporal pattern of immune and neuroendocrine correlates. Neuropsychopharmacology (1988) 0.76
Plasma neuropeptide Y in anxiety disorders: findings in panic disorder and social phobia. Psychiatry Res (1996) 0.76
TSH response to TRH and family history of alcoholism. Biol Psychiatry (1990) 0.75
[Is the validated ICIQ-SF suitable for evaluation of OAB patients? A data analysis of intravesicular botulinum toxin therapy]. Urologe A (2014) 0.75
Regulation of the anorectic drug recognition site during glucoprivic feeding. Brain Res Bull (1992) 0.75
Dopaminergic denervation increases [3H](+)-amphetamine binding in the rat striatum. Eur J Pharmacol (1985) 0.75
Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity. Brain Res (1993) 0.75
[Ischemia, alkalosis and acute respiratory acidosis and their effects on cerebral output (Xenon 133) and on ultrastructure of the nervous system]. Neurochirurgie (1971) 0.75
Response of three hormones to diazepam challenge in sons of alcoholics and controls. Alcohol Clin Exp Res (1991) 0.75
Glucostatic regulation of hypothalamic and brainstem [3H](+)-amphetamine binding during food deprivation and refeeding. Eur J Pharmacol (1986) 0.75
The effect of clorgyline on noradrenergic function. Psychopharmacology (Berl) (1985) 0.75
Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. Clin Neuropharmacol (1993) 0.75